TECX
$31.48
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs).
Intraday
Recent News
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins
Tectonic Therapeutic (NASDAQ:TECX) used a virtual key opinion leader (KOL) event to outline its strategy for hereditary hemorrhagic telangiectasia (HHT) and highlight early clinical progress for TX2100, an investigational APJ antagonist designed to treat bleeding driven by dysregulated angiogenesis.
Daniel Lochner Bought 70% More Shares In Tectonic Therapeutic
Investors who take an interest in Tectonic Therapeutic, Inc. ( NASDAQ:TECX ) should definitely note that the Chief...
Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating
Tectonic Therapeutic, Inc. (NASDAQ:TECX) is one of the Best Micro-Cap Stocks to Invest in According to Analysts. On November 18, LifeSci Capital reiterated a Buy rating on Tectonic Therapeutic, Inc. (NASDAQ:TECX) stock with a price target of $88. Tectonic Therapeutic, Inc. (NASDAQ:TECX) is a biotechnology company that focuses on the discovery and development of therapeutic […]
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Bullish Tectonic Therapeutic Insiders Loaded Up On US$61.2m Of Stock
Multiple insiders secured a larger position in Tectonic Therapeutic, Inc. ( NASDAQ:TECX ) shares over the last 12...